This regulation amends the Medical Products Agency’s (LVFS 2011:10) list of narcotic drugs, detailing chemical substances, their classifications, and regulatory status.

Key aspects include:

  • Listings of controlled chemical compounds with complex structures
  • Differentiation between cannabis (above-ground parts of Cannabis plants) and hemp (eligible for agricultural support under EU rules)
  • Classification under Swedish and international regulatory frameworks
  • References to the 1971 Convention on Psychotropic Substances for international drug control
  • International Nonproprietary Names (INN) from the WHO for global identification of pharmaceutical substances

The document provides a comprehensive guide to narcotic substances, their legal status, and medicinal applications.

Source:

Region: Europe

pattern
pattern
Got questions? We’ve got answers!

Let's talk Regulatory!

Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.

Speak to an Expert